Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
AstraZeneca Pharma India Limited and Dr. Reddy’s Laboratories Ltd. Collaborate to marketing for Riax, a new brand of saxagliptin and Riax-M a fixed dose combination of saxagliptin with metformin. Both Riax and Riax M are trademarks of the AstraZeneca group. AZPIL already has two brands under the trademark Onglyza and Kombiglyze for saxagliptin and in fixed dose combination with metformin respectively, promoted and marketed in the Indian market.
OPTM Healthcare, with its ever evolving streak of innovating absolutely natural treatments with 100% recovery, has devised a remarkable alternative to treat osteoarthritis with phytomedicines. Its team of professional physicians has scientifically developed plant-originated Indian herbal medicines, known as phytomedicines, to use as an excellent cure for this disease along with many others.
(NewsVoir); Abbott, India’s leading multinational healthcare company announced the launch of ‘LiverHealth’, a new initiative aimed at providing access to an easy diagnosis of liver health and raising awareness of Hepatitis C (an infectious disease affecting the liver, caused by the Hepatitis C Virus) condition in India.
[adsense:336x280:8701650588]
(NewsVoir); With an aim to increase awareness on environmental issues and the citizen’s responsibilities towards it, Ahmedabad based Cadila Pharmaceuticals Ltd is going to celebrate ‘World Environment Day’ in a unique way. The Company will launch ‘Consume with Care and Sustainable Production’ awareness drive to conserve natural resources that are fast depleting. Other activities like poster competition, essay contest, quiz and slogan contest, based on the theme of ‘Sustainability and Consumption’ will also be organized at company’s various locations.
(NewsVoir); With Indian pharmaceutical exports to the United States and other markets showing a marked increase over the last year, government regulatory agencies have started emphasizing the need to ensure consistent quality of drugs manufactured in India. The drugs standardization compliance and regulatory requirements need to be at par with the international regulations, including the US FDA, allowing drug manufacturers to maintain competitive advantage.
US researchers have found that the more the hunter-gatherers smoke cannabis, the less they are infected by intestinal worms. The findings suggest that they may unconsciously be, in effect, smoking medical marijuana. The study appeared in the American Journal of Human Biology.
Siemens Healthcare planning to introduce the Magnetom Terra 7 Tesla MRI system to convert cutting-edge MRI research results into clinical application. This translation will allow user in less than ten minutes. New 7 Tesla MRI system provides the whole range of cutting-edge 7 Tesla research functionalities, and is based on the latest software platform syngo MR E11, identical to Siemens’ latest flagship 3 Tesla MRI systems, to enable consistent usability and protocol exchange. It is the world’s first ultra-high field research system ready for future clinical use with planned CE and FDA authorization to market for selected neurological and musculoskeletal MR imaging applications.
A leading international developer and manufacturer of advanced and innovative hearing healthcare solutions, Denmark-based GN ReSound, launched Resound LiNX2 in India, the world’s first full family of smart hearing aids. The world’s smartest hearing aid, ReSound LiNX2 takes the user experience to the next level with Spatial Sense . The new Spatial Sense technology gives users a vivid sense of space and speech in top-rated sound quality. ReSound LiNX2 is the fourth premium family of hearing aids to come out of GN ReSound’s proprietary 2.4 GHz wireless platform and builds on already industry-leading technologies in all areas of Smart Hearing (audiology, connectivity, design, and apps).
A team of researchers from CSIR-CIMAP (Council of Scientific and Industrial Research-Central Institute of Medical & Aromatic Plants) in Lucknow have successfully completed the genome sequencing of Tulsi (Basil) plant and very soon are expected to unravel the therapeutic secrets of its medical properties. This is the first report of complete genome sequence of a traditional and most respected medicinal plant of India, using a composite next generation sequencing technologies.
Sun Pharmaceutical Industries and AstraZeneca Pharma India (AZPIL) have entered agreement for distribution of AstraZeneca’s brand “Axcer”, a new brand of ticagrelor in India. This drug is used for the treatment of acute coronary syndrome (ACS). AZPIL already has a brand under the trademark “Brilinta”, for ticagrelor molecule, launched and marketed by AZPIL in India since 2012. This collaboration will provide customers access to this latest generation treatment option for ACS.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
